See also this year's filing and all EDGAR filings for this company.
PDF Report 0001633932_2024_ESSA_Pharma_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001633932, ESSA Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 148,796,878 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 325,253 |
| 4 | LiabilitiesCurrent | 3,495,071 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,550,364 |
| 9 | ResearchAndDevelopmentExpense | 18,273,756 |
| 10 | remainder_Expenses | -22,054 |
| 11 | remainder_Revenues | 24,621,129 |
| 12 | remainder_NetIncome | 6,710 |
| 13 | remainder_ComprehensiveNetIncome | -58,517 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 149,122,131 |
| 1 | Liabilities | 3,495,071 |
| 2 | Expenses | 28,802,066 |
| 3 | Revenues | 24,621,129 |
| 4 | StockholdersEquity | 145,627,060 |
| 5 | NetIncome | -4,174,227 |
| 6 | ComprehensiveNetIncome | -4,203,486 |
| 7 | BaseVar | 103,052,812 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.11 |
| 9 | EconomicCapitalRatio | 4.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
